Schlesinger Michael A.'s Form 4 filing
Ortho Clinical Diagnostics Holdings plc (OCDX) · filed Apr 6, 2022
- Accession no.
- 0001209191-22-023458
- Filed
- Apr 6, 2022
- Trade date
- Apr 4, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.65M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schlesinger Michael A.CIK 0001839441 | Officer (EVP, GC and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | Ordinary Shares, $0.00001 par value | MOption exerciseAcquired | +88,043 | $6.28 | +$552,910.04 | 175,680 | Direct | |
| Apr 4, 2022 | Ordinary Shares, $0.00001 par value | SSaleDisposed | −88,043 | $18.77F2,F3 | −$1,652,567.11 | 87,637 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | Ordinary Shares, $0.00001 par value | MOption exerciseDisposed | −88,043 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sales price for the price increments ranging from $18.6200 to $18.8800.
Referenced by the price of 1 transaction in Table I.